Jazz Pharmaceuticals Announces Second Quarter 2026 Financial Results
PR Newswire•03/08/2026•16:05 ET
0
Whiz Insights
Jazz Pharmaceuticals Announces Second Quarter 2026 Financial Results
– Continued commercial execution drives record total revenues of $1.2 billion (+16% YoY) –
Get started
Create a free account to read the full story.